{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:26:11Z","timestamp":1770960371237,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,5]],"date-time":"2014-12-05T00:00:00Z","timestamp":1417737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00417-014-2875-0","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T02:52:52Z","timestamp":1417661572000},"page":"409-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model"],"prefix":"10.1007","volume":"253","author":[{"given":"Christian","family":"Wertheimer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Siedlecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Kook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang J.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie","family":"Klingenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselm","family":"Kampik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Eibl-Lindner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,5]]},"reference":[{"key":"2875_CR1","doi-asserted-by":"crossref","unstructured":"Findl O, Buehl W, Bauer P, Sycha T (2010) Interventions for preventing posterior capsule opacification. Cochrane Database Syst Rev CD003738 doi: 10.1002\/14651858.CD003738.pub3","DOI":"10.1002\/14651858.CD003738.pub3"},{"key":"2875_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0039-6257(92)90073-3","volume":"37","author":"DJ Apple","year":"1992","unstructured":"Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UFC, Tsai JC, Castaneda VE, Hoggatt JP, Kostick AMP (1992) Posterior capsule opacification\u2606. Surv Ophthalmol 37:73\u2013116. doi: 10.1016\/0039-6257(92)90073-3","journal-title":"Surv Ophthalmol"},{"key":"2875_CR3","author":"FT Kretz","year":"2014","unstructured":"Kretz FT, Auffarth GU (2014) Are lens implant modifications the best way to prevent posterior capsule opacification? Br J Ophthalmol. doi: 10.1136\/bjophthalmol-2014-304992","journal-title":"Br J Ophthalmol"},{"key":"2875_CR4","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.jcrs.2013.06.021","volume":"39","author":"C Leydolt","year":"2013","unstructured":"Leydolt C, Kriechbaum K, Schriefl S, Pachala M, Menapace R (2013) Posterior capsule opacification and neodymium:YAG rates with 2 single-piece hydrophobic acrylic intraocular lenses: three-year results. J Cataract Refract Surg 39:1886\u20131892","journal-title":"J Cataract Refract Surg"},{"key":"2875_CR5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jcrs.2008.11.044","volume":"35","author":"L Vock","year":"2009","unstructured":"Vock L, Menapace R, Stifter E, Georgopoulos M, Sacu S, Buhl W (2009) Posterior capsule opacification and neodymium:YAG laser capsulotomy rates with a round-edged silicone and a sharp-edged hydrophobic acrylic intraocular lens 10\u00a0years after surgery. J Cataract Refract Surg 35:459\u2013465. doi: 10.1016\/j.jcrs.2008.11.044","journal-title":"J Cataract Refract Surg"},{"key":"2875_CR6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jfo.2013.08.009","volume":"37","author":"D Martiano","year":"2014","unstructured":"Martiano D, Cochener B (2014) Multifocal IOLs in the high myope, 6-year follow-up. J Fr Ophtalmol 37:393\u2013399. doi: 10.1016\/j.jfo.2013.08.009","journal-title":"J Fr Ophtalmol"},{"key":"2875_CR7","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1167\/iovs.02-0634","volume":"44","author":"WR Meacock","year":"2003","unstructured":"Meacock WR, Spalton DJ, Boyce J, Marshall J (2003) The effect of posterior capsule opacification on visual function. Invest Ophthalmol Vis Sci 44:4665\u20134669","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2875_CR8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/exer.2001.1153","volume":"74","author":"I Michael Wormstone","year":"2002","unstructured":"Michael Wormstone I (2002) Posterior capsule opacification: a cell biological perspective. Exp Eye Res 74:337\u2013347. doi: 10.1006\/exer.2001.1153","journal-title":"Exp Eye Res"},{"key":"2875_CR9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0886-3350(13)80004-1","volume":"19","author":"JA Davison","year":"1993","unstructured":"Davison JA (1993) Capsule contraction syndrome. J Cataract Refract Surg 19:582\u2013589","journal-title":"J Cataract Refract Surg"},{"key":"2875_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1444-0938.2011.00640.x","volume":"95","author":"HH Lam","year":"2012","unstructured":"Lam HH, Visvaraja S (2012) Spontaneous dislocation of intraocular lens as a late complication of uncomplicated cataract surgery: a case series. Clin Exp Optom: J Aust Optometrical Assoc 95:99\u2013102. doi: 10.1111\/j.1444-0938.2011.00640.x","journal-title":"Clin Exp Optom: J Aust Optometrical Assoc"},{"key":"2875_CR11","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jcrs.2007.06.056","volume":"33","author":"G Cleary","year":"2007","unstructured":"Cleary G, Spalton DJ, Koch DD (2007) Effect of square-edged intraocular lenses on neodymium:YAG laser capsulotomy rates in the United States. J Cataract Refract Surg 33:1899\u20131906. doi: 10.1016\/j.jcrs.2007.06.056","journal-title":"J Cataract Refract Surg"},{"key":"2875_CR12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jcrs.2012.09.028","volume":"39","author":"KH Eibl","year":"2013","unstructured":"Eibl KH, Wertheimer C, Kernt M, Wolf A, Kook D, Haritoglou C, Kampik A (2013) Alkylphosphocholines for intraocular lens coating. J Cataract Refract Surg 39:438\u2013445. doi: 10.1016\/j.jcrs.2012.09.028","journal-title":"J Cataract Refract Surg"},{"key":"2875_CR13","first-page":"622","volume":"44","author":"L Zhang","year":"2008","unstructured":"Zhang L, Wang N-L, Zhang W, Chang Z-J (2008) Suppression of cell proliferation by inhibitors to redox signaling in human lens epithelial cells. Zhonghua yan ke za zhi. Chin J Ophthalmol 44:622\u2013628","journal-title":"Chin J Ophthalmol"},{"key":"2875_CR14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcrs.2005.08.063","volume":"32","author":"J Kampmeier","year":"2006","unstructured":"Kampmeier J, Baldysiak-Figiel A, Jong-Hesse Y, Lang GK, Lang GE (2006) Effect of growth factors on proliferation and expression of growth factor receptors in a human lens epithelial cell line. J Cataract Refract Surg 32:510\u2013514. doi: 10.1016\/j.jcrs.2005.08.063","journal-title":"J Cataract Refract Surg"},{"key":"2875_CR15","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1167\/iovs.03-1187","volume":"45","author":"JM Maidment","year":"2004","unstructured":"Maidment JM, Duncan G, Tamiya S, Collison DJ, Wang L, Wormstone IM (2004) Regional differences in tyrosine kinase receptor signaling components determine differential growth patterns in the human lens. Invest Ophthalmol Vis Sci 45:1427\u20131435","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2875_CR16","first-page":"2349","volume":"17","author":"W-R Huang","year":"2011","unstructured":"Huang W-R, Fan X-X, Tang X (2011) SiRNA targeting EGFR effectively prevents posterior capsular opacification after cataract surgery. Mol Vis 17:2349\u20132355","journal-title":"Mol Vis"},{"key":"2875_CR17","author":"C Wertheimer","year":"2013","unstructured":"Wertheimer C, Liegl R, Kernt M, Mayer W, Docheva D, Kampik A, Eibl-Lindner KH (2013) EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification. Graefes Arch Clin Exp Ophthalmol. doi: 10.1007\/s00417-013-2257-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2875_CR18","author":"C Wertheimer","year":"2014","unstructured":"Wertheimer C, Liegl R, Kernt M, Docheva D, Kampik A, Eibl-Lindner KH (2014) EGFR-Blockade with erlotinib reduces EGF and TGF-beta2 expression and the actin-cytoskeleton which influences different aspects of cellular migration in lens epithelial cells. Curr Eye Res. doi: 10.3109\/02713683.2014.888453","journal-title":"Curr Eye Res"},{"key":"2875_CR19","first-page":"257","volume":"5","author":"P Perrotte","year":"1999","unstructured":"Perrotte P, Matsumoto T, Inoue K, Kuniyasu H, Eve BY, Hicklin DJ, Radinsky R, Dinney CP (1999) Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 5:257\u2013265","journal-title":"Clin Cancer Res"},{"key":"2875_CR20","doi-asserted-by":"crossref","first-page":"25915","DOI":"10.1074\/jbc.270.43.25915","volume":"270","author":"S Grugel","year":"1995","unstructured":"Grugel S, Finkenzeller G, Weindel K, Barleon B, Marme D (1995) Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3\u00a0T3 cells. J Biol Chem 270:25915\u201325919","journal-title":"J Biol Chem"},{"key":"2875_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/363083a0","volume":"363","author":"M Rozakis-Adcock","year":"1993","unstructured":"Rozakis-Adcock M, Fernley R, Wade J, Pawson T, Bowtell D (1993) The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363:83\u201385. doi: 10.1038\/363083a0","journal-title":"Nature"},{"key":"2875_CR22","first-page":"4575","volume":"55","author":"J Rak","year":"1995","unstructured":"Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS (1995) Mutant ras oncogenes upregulate VEGF\/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55:4575\u20134580","journal-title":"Cancer Res"},{"key":"2875_CR23","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1128\/MCB.12.11.5078","volume":"12","author":"S Kizaka-Kondoh","year":"1992","unstructured":"Kizaka-Kondoh S, Sato K, Tamura K, Nojima H, Okayama H (1992) Raf-1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet-derived growth factor. Mol Cell Biol 12:5078\u20135086","journal-title":"Mol Cell Biol"},{"key":"2875_CR24","unstructured":"FDA (2004) FDA label information for Gefitinib [online]. FDA, http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2005\/021399s008lbl.pdf . Accessed 24 July 2014"},{"key":"2875_CR25","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.exer.2006.06.013","volume":"83","author":"IM Wormstone","year":"2006","unstructured":"Wormstone IM, Anderson IK, Eldred JA, Dawes LJ, Duncan G (2006) Short-term exposure to transforming growth factor beta induces long-term fibrotic responses. Exp Eye Res 83:1238\u20131245. doi: 10.1016\/j.exer.2006.06.013","journal-title":"Exp Eye Res"},{"key":"2875_CR26","first-page":"906","volume":"37","author":"CS Liu","year":"1996","unstructured":"Liu CS, Wormstone IM, Duncan G, Marcantonio JM, Webb SF, Davies PD (1996) A study of human lens cell growth in vitro. A model for posterior capsule opacification. Investig Ophthalmol Vis Sci 37:906\u2013914","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2875_CR27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/exer.2001.1153","volume":"74","author":"IM Wormstone","year":"2002","unstructured":"Wormstone IM (2002) Posterior capsule opacification: a cell biological perspective. Exp Eye Res 74:337\u2013347. doi: 10.1006\/exer.2001.1153","journal-title":"Exp Eye Res"},{"key":"2875_CR28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1034\/j.1600-0420.2000.078002130.x","volume":"78","author":"J Bednarz","year":"2000","unstructured":"Bednarz J, Teifel M, Friedl P, Engelmann K (2000) Immortalization of human corneal endothelial cells using electroporation protocol optimized for human corneal endothelial and human retinal pigment epithelial cells. Acta Ophthalmol Scand 78:130\u2013136","journal-title":"Acta Ophthalmol Scand"},{"key":"2875_CR29","first-page":"3094","volume":"35","author":"UP Andley","year":"1994","unstructured":"Andley UP, Rhim JS, Chylack LT, Fleming TP (1994) Propagation and immortalization of human lens epithelial cells in culture. Invest Ophthalmol Vis Sci 35:3094\u20133102","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2875_CR30","first-page":"864","volume":"43","author":"GA Limb","year":"2002","unstructured":"Limb GA, Salt TE, Munro PMG, Moss SE, Khaw PT (2002) In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1). Invest Ophthalmol Vis Sci 43:864\u2013869","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2875_CR31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","volume":"62","author":"KC Dunn","year":"1996","unstructured":"Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM (1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62:155\u2013169. doi: 10.1006\/exer.1996.0020","journal-title":"Exp Eye Res"},{"key":"2875_CR32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"2875_CR33","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1442-9071.2009.01921.x","volume":"36","author":"TD Walker","year":"2008","unstructured":"Walker TD (2008) Pharmacological attempts to reduce posterior capsule opacification after cataract surgery\u2013a review. Clin Exp Ophthalmol 36:883\u2013890. doi: 10.1111\/j.1442-9071.2009.01921.x","journal-title":"Clin Exp Ophthalmol"},{"key":"2875_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000267024","volume":"22","author":"JM Ruiz","year":"1990","unstructured":"Ruiz JM, Medrano M, Alio JL (1990) Inhibition of posterior capsule opacification by 5-fluorouracil in rabbits. Ophthalmic Res 22:201\u2013208","journal-title":"Ophthalmic Res"},{"key":"2875_CR35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archophthalmol.2009.3","volume":"127","author":"N Awasthi","year":"2009","unstructured":"Awasthi N, Guo S, Wagner BJ (2009) Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol 127:555\u2013562. doi: 10.1001\/archophthalmol.2009.3","journal-title":"Arch Ophthalmol"},{"key":"2875_CR36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s10384-008-0646-3","volume":"53","author":"S Kang","year":"2009","unstructured":"Kang S, Choi JA, Joo CK (2009) Comparison of posterior capsular opacification in heparin-surface-modified hydrophilic acrylic and hydrophobic acrylic intraocular lenses. Jpn J Ophthalmol 53:204\u2013208. doi: 10.1007\/s10384-008-0646-3","journal-title":"Jpn J Ophthalmol"},{"key":"2875_CR37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.etap.2005.07.012","volume":"21","author":"IM Wormstone","year":"2006","unstructured":"Wormstone IM, Collison DJ, Hansom SP, Duncan G (2006) A focus on the human lens in vitro. Environ Toxicol Pharmacol 21:215\u2013221. doi: 10.1016\/j.etap.2005.07.012","journal-title":"Environ Toxicol Pharmacol"},{"key":"2875_CR38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.exer.2008.10.016","volume":"88","author":"IM Wormstone","year":"2009","unstructured":"Wormstone IM, Wang L, Liu CS (2009) Posterior capsule opacification. Exp Eye Res 88:257\u2013269. doi: 10.1016\/j.exer.2008.10.016","journal-title":"Exp Eye Res"},{"key":"2875_CR39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1167\/iovs.03-0694","volume":"45","author":"DJ Collison","year":"2004","unstructured":"Collison DJ, Wang L, Wormstone IM, Duncan G (2004) Spatial characteristics of receptor-induced calcium signaling in human lens capsular bags. Invest Ophthalmol Vis Sci 45:200\u2013205","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2875_CR40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/iovs.11-8851","volume":"53","author":"LJ Dawes","year":"2012","unstructured":"Dawes LJ, Illingworth CD, Wormstone IM (2012) A fully human in vitro capsular bag model to permit intraocular lens evaluation. Invest Ophthalmol Vis Sci 53:23\u201329. doi: 10.1167\/iovs. 11-8851","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2875_CR41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0014-4835(84)90079-4","volume":"39","author":"LZ Bito","year":"1984","unstructured":"Bito LZ (1984) Species differences in the responses of the eye to irritation and trauma: a hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research. Exp Eye Res 39:807\u2013829","journal-title":"Exp Eye Res"},{"key":"2875_CR42","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jcrs.2008.07.029","volume":"34","author":"W Buehl","year":"2008","unstructured":"Buehl W, Findl O (2008) Effect of intraocular lens design on posterior capsule opacification. J Cataract Refract Surg 34:1976\u20131985. doi: 10.1016\/j.jcrs.2008.07.029","journal-title":"J Cataract Refract Surg"},{"key":"2875_CR43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1167\/iovs.10-6001","volume":"52","author":"H Xu","year":"2011","unstructured":"Xu H, Chen M, Forrester JV, Lois N (2011) Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion. Invest Ophthalmol Vis Sci 52:249\u2013255. doi: 10.1167\/iovs.10-6001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2875_CR44","first-page":"1410","volume":"39","author":"N Wallentin","year":"1998","unstructured":"Wallentin N, Wickstrom K, Lundberg C (1998) Effect of cataract surgery on aqueous TGF-beta and lens epithelial cell proliferation. Invest Ophthalmol Vis Sci 39:1410\u20131418","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2875_CR45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0886-3350(13)80142-3","volume":"21","author":"M Pande","year":"1995","unstructured":"Pande M, Shah SM, Spalton DJ (1995) Correlations between aqueous flare and cells and lens surface cytology in eyes with poly(methyl methacrylate) and heparin-surface-modified intraocular lenses. J Cataract Refract Surg 21:326\u2013330","journal-title":"J Cataract Refract Surg"},{"key":"2875_CR46","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/archopht.1991.01080120065027","volume":"109","author":"F Malecaze","year":"1991","unstructured":"Malecaze F, Chollet P, Cavrois E, Vita N, Arne JL, Ferrara P (1991) Role of interleukin 6 in the inflammatory response after cataract surgery. An Exp Clin Stud Arch Ophthalmol 109:1681\u20131683","journal-title":"An Exp Clin Stud Arch Ophthalmol"},{"key":"2875_CR47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00003226-200005000-00002","volume":"19","author":"HF Edelhauser","year":"2000","unstructured":"Edelhauser HF (2000) The resiliency of the corneal endothelium to refractive and intraocular surgery. Cornea 19:263\u2013273","journal-title":"Cornea"},{"key":"2875_CR48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00055735-199602000-00009","volume":"7","author":"DR Hardten","year":"1996","unstructured":"Hardten DR (1996) The cornea in cataract and intraocular lens surgery. Curr Opin Ophthalmol 7:43\u201348","journal-title":"Curr Opin Ophthalmol"},{"key":"2875_CR49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00520-012-1645-y","volume":"21","author":"DS Borkar","year":"2013","unstructured":"Borkar DS, Lacouture ME, Basti S (2013) Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year review. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 21:1167\u20131174. doi: 10.1007\/s00520-012-1645-y","journal-title":"Support Care Cancer: Off J Multinatl Assoc Support Care Cancer"},{"key":"2875_CR50","unstructured":"FDA (2005) FDA labled information for Gefitinib. FDA"},{"key":"2875_CR51","first-page":"379132","volume":"2012","author":"E Ibrahim","year":"2012","unstructured":"Ibrahim E, Dean WH, Price N, Gomaa A, Ayre G, Guglani S, Sallam A (2012) Perforating corneal ulceration in a patient with lung metastatic adenocarcinoma treated with gefitinib: a case report. Case Rep Ophthalmol Med 2012:379132. doi: 10.1155\/2012\/379132","journal-title":"Case Rep Ophthalmol Med"},{"key":"2875_CR52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.eye.6701630","volume":"19","author":"AB Tullo","year":"2005","unstructured":"Tullo AB, Esmaeli B, Murray PI, Bristow E, Forsythe BJ, Faulkner K (2005) Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (\u2018Iressa\u2019, ZD1839) in Phase I and II clinical trials. Eye 19:729\u2013738. doi: 10.1038\/sj.eye.6701630","journal-title":"Eye"},{"key":"2875_CR53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.critrevonc.2013.08.003","volume":"89","author":"G Bronte","year":"2014","unstructured":"Bronte G, Rolfo C, Giovannetti E, Cicero G, Pauwels P, Passiglia F, Castiglia M, Rizzo S, Vullo FL, Fiorentino E, Van Meerbeeck J, Russo A (2014) Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects. Crit Rev Oncol\/Hematol 89:300\u2013313. doi: 10.1016\/j.critrevonc.2013.08.003","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"2875_CR54","first-page":"239","volume":"39","author":"AF Rahman","year":"2014","unstructured":"Rahman AF, Korashy HM, Kassem MG (2014) Profiles of drug substances, excipients, and related methodology. Gefitinib 39:239\u2013264. doi: 10.1016\/B978-0-12-800173-8.00005-2","journal-title":"Gefitinib"},{"key":"2875_CR55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM (2005) The blood\u2013brain barrier: bottleneck in brain drug development. NeuroRx: J Am Soc Exp NeuroTher 2:3\u201314. doi: 10.1602\/neurorx.2.1.3","journal-title":"NeuroRx: J Am Soc Exp NeuroTher"},{"key":"2875_CR56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1755-3768.2008.01419.x","volume":"88","author":"M Kugelberg","year":"2010","unstructured":"Kugelberg M, Shafiei K, van der Ploeg I, Zetterstrom C (2010) Intraocular lens as a drug delivery system for dexamethasone. Acta Ophthalmol 88:241\u2013244. doi: 10.1111\/j.1755-3768.2008.01419.x","journal-title":"Acta Ophthalmol"},{"key":"2875_CR57","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00347-013-2904-0","volume":"110","author":"KH Eibl-Lindner","year":"2013","unstructured":"Eibl-Lindner KH, Liegl R, Wertheimer C, Kampik A (2013) Intraocular lens as a drug delivery device. Ophthalmol: Z Dtsch Ophthalmologischen Ges 110:990\u2013994. doi: 10.1007\/s00347-013-2904-0","journal-title":"Ophthalmol: Z Dtsch Ophthalmologischen Ges"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2875-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-014-2875-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2875-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T03:51:46Z","timestamp":1566100306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-014-2875-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,5]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["2875"],"URL":"https:\/\/doi.org\/10.1007\/s00417-014-2875-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,5]]}}}